UTILIZTION OF THE SUZUKI COUPLING TO ENHANCE THE ANTITUBERCULOSIS ACTIVITY OF ARYL OXAZOLES. (Q35336015)

7 August 2017

UTILIZTION OF THE SUZUKI COUPLING TO ENHANCE THE ANTITUBERCULOSIS ACTIVITY OF ARYL OXAZOLES. (English)

1 reference

7 August 2017

Garrett C Moraski

1

0 references

Scott G. Franzblau

object named as

Scott G Franzblau

series ordinal

2

0 references

author name string

Marvin J Miller

series ordinal

3

1 reference

PubMed ID

22003265

7 August 2017

language of work or name

1 reference

1 March 2010

1 reference

7 August 2017

1 reference

7 August 2017

80

1 reference

7 August 2017

977-988

1 reference

7 August 2017

2

1 reference

Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192507

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192507

The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192507

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192507

Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192507

Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192507

Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192507

Vero cell assay validation of an alternative to the Ph. Eur. diphtheria potency tests.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3192507

Synthesis and studies of catechol-containing mycobactin S and T analogs

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22003265

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

WHO policies for tuberculosis control

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22003265

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22003265

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3987/COM-09-S(S)69

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

PubMed ID

22003265